DAVID DAY: Open Payments
NPI 1073234068 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $197 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $49 |
| PFIZER INC. | 2 | $43 |
| Amgen Inc. | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| BridgeBio Pharma, Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Lilly USA, LLC | 1 | $17 |
Products named: VYNDAQEL, VERQUVO, REPATHA, EVKEEZA, Attruby, FARXIGA, MOUNJARO, CAPVAXIVE.
Industry payments across ID — which companies pay providers there.
